Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition comprising a combination of DNA methylation inhibitor and a vitamin D receptor agonist for the treatment of drug resistant cancer or for the prevention of tumor relapse

Composition comprising a combination of DNA methylation inhibitor and a vitamin D receptor agonist for the treatment of drug resistant cancer or for the prevention of tumor relapse

US Patent 10111896 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Masitinib for the treatment of sickle cell disease2025
Masitinib for the treatment of sickle cell disease2025
Methods and pharmaceutical compositions for the treatment of diseases mediated b2023
Methods and pharmaceutical compositions for the treatment of mast cell diseases2022
Methods and pharmaceutical compositions for the treatment of systemic mastocytos2021
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-12020
Use of hydroxycarbamide for preventing retinal nonperfusion2020
Methods for determining the risk of acute graft versus host disease2018
Methods and pharmaceutical compositions for the treatment of beta-thalassemias2018
Methods and pharmaceutical compositions for the treatment of myelodysplastic syn2017
Methods and pharmaceutical compositions for treatment of retinal occlusion2016
Methods and compositions for the treatment of β-thalassemia2016